Jiangsu GDK Biotechnology Co Ltd (688670) — Financial Flexibility Index
Jiangsu GDK Biotechnology Co Ltd (688670) has a Financial Flexibility Index of -0.36x as of December 2024. Free cash flow of CN¥-92.91 Million (operating CF CN¥-131.39 Million minus capex CN¥38.48 Million) represents 0% of total liabilities (CN¥255.33 Million). Check how resilient are Jiangsu GDK Biotechnology Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu GDK Biotechnology Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Jiangsu GDK Biotechnology Co Ltd across 8 annual periods. See 688670 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jiangsu GDK Biotechnology Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Jiangsu GDK Biotechnology Co Ltd. For the full company profile including market capitalisation, see 688670 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.36x | CN¥-92.91 Million | CN¥-131.39 Million | CN¥255.33 Million | ▼ -170.3% |
| 2023 | 0.52x | CN¥134.91 Million | CN¥80.90 Million | CN¥260.52 Million | ▼ -8.1% |
| 2022 | 0.56x | CN¥206.77 Million | CN¥38.60 Million | CN¥367.11 Million | ▼ -66.3% |
| 2021 | 1.67x | CN¥490.31 Million | CN¥103.93 Million | CN¥293.12 Million | ▲ +496.1% |
| 2020 | 0.28x | CN¥150.26 Million | CN¥109.46 Million | CN¥535.47 Million | ▲ +531.0% |
| 2019 | -0.07x | CN¥-32.92 Million | CN¥-54.05 Million | CN¥505.68 Million | ▲ +10.8% |
| 2018 | -0.07x | CN¥-29.26 Million | CN¥-35.48 Million | CN¥400.73 Million | ▼ -4151.2% |
| 2017 | 0.00x | CN¥647.73K | CN¥-33.24 Million | CN¥359.39 Million | — |